期刊文献+

盐酸法舒地尔对冠心病心力衰竭的临床疗效观察 被引量:7

下载PDF
导出
摘要 目的观察盐酸法舒地尔对冠心病心力衰竭的临床疗效。方法将90例冠心病心力衰竭患者随机分为两组,对照组45例仅给予常规治疗,治疗组45例在常规治疗的基础上加用盐酸法舒地尔。两组在治疗前当天和治疗后3个月末进行彩色多普勒超声心动图检查,获得左心室收缩末容量指数和舒张末容量指数及左心室射血分数、左心室体质量指数,治疗过程中观察并记录患者症状、体征、心率、血压及不良反应,治疗前后常规测定血脂、肾功能、肝功能、尿酸、电解质、血糖等各项生化指标的变化。结果盐酸法舒地尔治疗冠心病心力衰竭临床效果明显,临床症状显著改善,总有效率为91.1%,治疗后左心室收缩末容量和舒张末容量明显降低,左室射血分数明显提高,与治疗前和对照组比较差异具有统计学意义,各项生化指标在治疗前后差异无统计学意义,未发现明显不良反应。结论盐酸法舒地尔可较好地改善冠心病心力衰竭患者的心功能,增加运动耐力,提高生活质量,值得临床推广。
出处 《检验医学与临床》 CAS 2011年第10期1223-1225,共3页 Laboratory Medicine and Clinic
  • 相关文献

参考文献12

  • 1Leung T,Manser E,Tan L,et al.A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes[J].J Biol Chem,1995,270(49):29051-29054.
  • 2Funakoshi Y,Ichiki T,Shiookawa H,et al.Rho-kinase mediates angiotension II-induced monocyte chemottractant protein-l expression in rat vascular smooth muscle cells[J].Hypertension,2001,38(1):100-104.
  • 3Takeda K,Lchiki T,Tokunou T,et al.Critical role of Rho-kinrise and MEK/ERK pathways for angiotensin II induced plasminogen activator inhibitor type-4 gene expression[J].Arterioscler Thromb Vasc Biol,2001,21(5):868-873.
  • 4Sauzeau V,Le Mellionnec E,Bertoglio J,et al.Human urotermin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase[J].Circ Res,2001,88(11):1102-1104.
  • 5Shimokawa H,Takeshita A.Rho-kinase is an important therapeutic target in cardiovascular medicine[J].Arterioscler Thromb Vasc Biol,2005,25(9):1767-1775.
  • 6Loirand G,Guérin P,Pacaud P.Rho kinases in cardiovascular physiology and pathophysiology[J].Circ Res,2006,98(3):322-334.
  • 7Uehato M,Ishizaki T,Satoh H,et al.Calcium sensidzation of smooth muscle mediated by a Rho-associated protein kinase in hypertension[J].Nature,1997,389(6654):990-994.
  • 8张曼,屈晨,曾定尹.Rho/Rho激酶在压力负荷心力衰竭大鼠心肌组织的表达[J].中华心血管病杂志,2005,33(1):73-76. 被引量:52
  • 9罗洁,闵苏.新型脑、心血管活性药——法舒地尔[J].中国新药与临床杂志,2006,25(12):941-945. 被引量:47
  • 10Wang YX,Da Cunba V,Martin-McNulty B,et al.Inhibition of Rho-kinase by fasudil attenuated angiotensinⅡ-induced cardiac hypertrophy in apolipoprotein E deficient mice[J].Eur J pharmacol,2005,512(2-3):215-222.

二级参考文献35

  • 1张曼,曾定尹.法舒地尔对压力负荷心力衰竭大鼠的作用[J].中国医科大学学报,2004,33(6):484-486. 被引量:4
  • 2Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329.
  • 3Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646.
  • 4Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805.
  • 5Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249.
  • 6Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175.
  • 7Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327.
  • 8Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564.
  • 9Becker R,Merkely B,Bauer A,et al.Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping[J]. Cardiovascular Research, 2000,45(2):310-320.
  • 10Antonio M,Aguilara A,Reverta F,et al.Ntravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion[J]. General Pharmacology, 2000,35(3):143-147.

共引文献97

同被引文献38

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部